Development
Alnylam Pharmaceuticals, Inc.
ALNY
$300.83
-$7.17-2.33%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.38% | 16.95% | -0.64% | -5.55% | -3.22% |
Total Receivables | 0.72% | 47.50% | 0.55% | -7.79% | 28.97% |
Inventory | -6.92% | -4.66% | -23.83% | 2.26% | 11.67% |
Prepaid Expenses | -19.99% | 8.60% | 22.20% | -10.45% | 5.90% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -0.09% | 18.28% | -0.67% | -5.62% | 0.05% |
|
|||||
Total Current Assets | -0.09% | 18.28% | -0.67% | -5.62% | 0.05% |
Net Property, Plant & Equipment | -0.45% | -0.98% | -0.24% | -0.07% | 0.68% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -2.53% | -12.34% | 25.91% | -2.29% | 4.24% |
Total Assets | -0.24% | 12.83% | 0.31% | -4.35% | 0.31% |
|
|||||
Total Accounts Payable | -24.81% | 23.59% | -4.00% | -36.55% | 141.78% |
Total Accrued Expenses | -8.18% | 19.14% | 17.68% | -1.01% | 0.63% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 12.59% | 13.19% | 13.43% | -18.84% | 6.23% |
Total Finance Division Other Current Liabilities | 108.76% | 41.18% | 52.65% | -51.49% | -48.83% |
Total Other Current Liabilities | 108.76% | 41.18% | 52.65% | -51.49% | -48.83% |
Total Current Liabilities | 1.90% | 20.43% | 17.11% | -12.31% | -0.63% |
|
|||||
Total Current Liabilities | 1.90% | 20.43% | 17.11% | -12.31% | -0.63% |
Long-Term Debt | 0.53% | 0.58% | 0.62% | 1.50% | 0.94% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -1.86% | -2.25% | -2.31% | -0.74% | -1.87% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.15% | 5.68% | 8.64% | 2.20% | 28.63% |
Total Liabilities | 1.14% | 5.10% | 4.36% | -1.44% | 2.82% |
|
|||||
Common Stock & APIC | 1.10% | 1.35% | 1.92% | 1.05% | 1.86% |
Retained Earnings | -2.01% | 2.10% | -4.09% | -2.65% | -3.26% |
Treasury Stock & Other | 27.72% | 12.79% | 5.22% | 12.38% | -1.99% |
Total Common Equity | -33.03% | 59.36% | -57.43% | -63.84% | -133.93% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -33.03% | 59.36% | -57.43% | -63.84% | -133.93% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -33.03% | 59.36% | -57.43% | -63.84% | -133.93% |
|